Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.55 |
| ▸ | LPL | P06858 | 13/20 | 0.55 |
| ▸ | P4HB | P07237 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17878513 | 0.99 | LIPG (0.53) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL20964185 | 0.99 | LIPG (0.53) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL16383444 | 0.97 | LIPG (0.56) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL31601991 | 0.96 | LIPG (0.58) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL23308389 | 0.94 | LIPG (0.59) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL30386638 | 0.94 | LIPG (0.59) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL18561843 | 0.93 | LIPG (0.61) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL22698943 | 0.92 | LIPG (0.51) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL15552944 | 0.91 | LIPG (0.59) | LIPGLPLP4HBDGAT1IRAK4 | |
| SCHEMBL30387012 | 0.91 | LIPG (0.59) | LIPGLPLP4HBDGAT1IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9957441-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9957441-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160190467-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AOC2, TYR, TAAR1 | LIPG 3199/4885LPL 2918/4885P4HB 4637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.